Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$56.6 - $89.9 $2,773 - $4,405
-49 Reduced 3.59%
1,315 $91,000
Q1 2022

May 11, 2022

SELL
$60.15 - $84.52 $902 - $1,267
-15 Reduced 1.09%
1,364 $113,000
Q4 2021

Jan 10, 2022

SELL
$75.08 - $121.99 $2,252 - $3,659
-30 Reduced 2.13%
1,379 $104,000
Q3 2021

Nov 24, 2021

SELL
$116.17 - $194.55 $580 - $972
-5 Reduced 0.35%
1,409 $164,000
Q2 2021

Jul 30, 2021

BUY
$130.4 - $225.58 $165,868 - $286,937
1,272 Added 895.77%
1,414 $314,000
Q2 2020

Jul 10, 2020

BUY
$57.2 - $74.41 $1,029 - $1,339
18 Added 14.52%
142 $8,000
Q1 2020

Apr 15, 2020

BUY
$57.05 - $95.75 $7,074 - $11,873
124 New
124 $8,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.07B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.